Difference between revisions of "NM Coordinating Committee"

From QIBA Wiki
Jump to: navigation, search
m
Line 14: Line 14:
 
::* [[PET_Amyloid_Biomarker_Ctte]]
 
::* [[PET_Amyloid_Biomarker_Ctte]]
 
::* [[SPECT_Biomarker_Ctte]]
 
::* [[SPECT_Biomarker_Ctte]]
 +
::* TC99m Biomarker Committee [page coming soon]
 +
::* I-123 Biomarker Committee [page coming soon]
  
 
==Meetings==
 
==Meetings==
  
 
* Tcons are held Quarterly. Contact the secretary for details.
 
* Tcons are held Quarterly. Contact the secretary for details.

Revision as of 14:54, 11 July 2018

Chairs: Richard Wahl, MD (Co-chair), Anne Smith, PhD (Co-chair), P. David Mozley, MD (Vice-chair)
Secretary: Susan Stanfa (RSNA Staff)

Roster


Scope

The NM Coordinating Committee coordinates Biomarker Committees based on NM.

  • Considering and proposing new candidate Biomarker Committees to the Steering Committee
  • Preparing/Reviewing and Prioritizing groundwork funding proposals for submission to the Steering Committee
  • Approving for publication Biomarker Profiles developed by the NM Biomarker Committees

Meetings

  • Tcons are held Quarterly. Contact the secretary for details.